Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Dave, Nellesen"'
Autor:
Ahmar U. Zaidi, Alexander K. Glaros, Soyon Lee, Taiji Wang, Rhea Bhojwani, Eric Morris, Breanne Donohue, Jincy Paulose, Şerban R. Iorga, Dave Nellesen
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-12 (2021)
Abstract Background and purpose Sickle cell disease (SCD) is a collection of rare inherited blood disorders affecting approximately 100,000 people in the U.S. and 20–25 million people globally. Individuals with SCD experience recurrent episodes of
Externí odkaz:
https://doaj.org/article/86a5495ff746458d910da729d8cdcc5e
Publikováno v:
Sexual Medicine Reviews. 11:52-60
Introduction Ischemic priapism is a serious condition characterized by a persistent and painful involuntary erection. Patients with sickle cell disease (SCD) are at an elevated risk of experiencing priapism, with approximately 40% experiencing priapi
Autor:
Şerban R. Iorga, Rhea Bhojwani, Soyon Lee, Taiji Wang, Dave Nellesen, Jincy Paulose, Eric Morris, Ahmar U. Zaidi, Breanne Donohue, Alexander K. Glaros
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-12 (2021)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background and purpose Sickle cell disease (SCD) is a collection of rare inherited blood disorders affecting approximately 100,000 people in the U.S. and 20–25 million people globally. Individuals with SCD experience recurrent episodes of severe an
Publikováno v:
Pharmacoeconomics
Autor:
Anem Waheed, Samantha Kaufhold, Che-Rung Liu, Jiali Lei, Dave Nellesen, Anumaxine Lincy Geevarghese, Glorian P. Yen
Publikováno v:
Blood. 140:11451-11452
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(4)
Sickle cell disease (SCD) patients are at high risk of central nervous system (CNS) complications and may experience significant morbidity. The study was conducted to describe the comprehensive burden of SCD-related CNS complications and to identify
Publikováno v:
Advances in therapy. 39(4)
Tazemetostat is an enhancer of zeste homolog 2 (EZH2) inhibitor recommended for patients with relapsed/refractory (R/R) follicular lymphoma (FL) after demonstrating single-agent, antitumor activity in patients with wild-type or mutant EZH2. The phosp
Publikováno v:
Journal of managed carespecialty pharmacy. 27(10)
BACKGROUND: Promacta (eltrombopag; EPAG) and Nplate (romiplostim; ROMI) have not been compared in head-to-head trials for treatment of chronic immune thrombocytopenia (cITP); however, indirect trea...
Autor:
Aparna Gomes, Chelsea Norregaard, Aaron Miller, Dave Nellesen, Erin M. Sullivan, Raymond Mankoski, David Proudman
Publikováno v:
JAMA Netw Open
Importance With the approval of avapritinib for adults with unresectable or metastatic gastrointestinal stromal tumors (GISTs) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 variant, including PDGFRA D842V variants, and Na
Autor:
David Proudman, Deepshekhar Gupta, Dave Nellesen, Alex Wong, Jay Yang, Beth Kamp, Khalid Mamlouk, Bruce Cheson
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S244